Food and Drug Administration

Center for Drug Evaluation and Research

Endocrinologic and Metabolic Drugs Advisory Committee

Hilton Silver Spring, 8727 Colesville Road, Silver Spring, MD

Open Public Hearing

September 25, 2002

Clinical Trials for New Osteoporosis Treatments



  1. Ginger Constantine, M.D., Vice President Womens Health, Research Wyeth

  3. Willard Dere, M.D., Vice President, Endocrinology, Lilly

  5. Thomas Marriott, Ph.D., Vice President, Development Research, NPS Pharmaceuticals.

  7. Amy Allina, National Women’s Health Network

  9. GlaxoSmithKline written submission


6. Roche Pharmaceuticals written submission